Company Overview and News

 
Manas Resources’ shares rise on move to acquire West African gold projects

2018-01-23 proactiveinvestors.com.au
Manas Resources Limited’s (ASX:MSR) shares are trading 50% higher intra-day at $0.006 after singing agreements to acquire interests in the Gonsan and Bouaké Nord Projects in Côte d’Ivoire, West Africa.

 
Ferrum Crescent and Manas Resources were this morning's top movers

2018-01-23 proactiveinvestors.com.au
Ferrum Crescent Limited (ASX:FCR) and Manas Resources Limited (ASX:MSR) were the top gainers on the ASX this morning.

 
UPDATE 1-Investors wary as Tanzania moves to assert more control over mines

2017-09-25 reuters
NAIROBI/LONDON (Reuters) - New laws and a crackdown on mining firms in Tanzania has slowed fresh investment in what has long been seen as one of Africa’s brightest mining prospects as companies assess the consequences of government efforts to claim a bigger slice of the pie.

 
Investors wary as Tanzania moves to assert more control over mines

2017-09-24 reuters
NAIROBI/LONDON (Reuters) - New laws and a crackdown on mining firms in Tanzania has slowed fresh investment in what has long been seen as one of Africa’s brightest mining prospects as companies assess the consequences of government efforts to claim a bigger slice of the pie.

 
Resolute Mining - 300K Oz/Year Gold Producer Trading Near 52-Week Lows

2017-07-22 seekingalpha
Resolute Mining is underperforming its peer group since the GDXJ rebalancing act ended on June 16.

 
Manas Resources among ASX % Gainers at midday

2017-05-31 proactiveinvestors.com.au

 
Ground geophysics identifies drill targets

2016-12-13 londonstockexchange
Legendary is pleased to announce that it has received the results of the geophysical study carried out by Manas Resources LLP ("Manas") (announced on 25 August 2016), intended to better define and delineate known and potential gold mineralisation in two subareas of the 66km2 license area in Sultan Sary, Narynskaya Oblast, Kyrgyzstan.

 
Results for the year ended 31 March 2016

2016-09-08 londonstockexchange
·     Investments (fixed asset investments and current asset investments) at £4,275,000 (2015: £1,785,000), a rise of 139%

 
Manas Resources Ltd is Wednesday's ASX Most Traded with 194 million

2016-08-31 proactiveinvestors.com.au
Proactive Investors is a global leader reporting financial news, media, research and hosts events for listed emerging growth companies and investors across four continents.

 
Manas Resources Ltd bags cash from asset sale in Kyrgyz Republic

2016-08-31 proactiveinvestors.com.au
Manas Resources Ltd (ASX:MSR) will pocked US$10.5 million (A$14 million) from the sale of all assets in the Kyrgyz Republic. The sale is across two agreements. First, a binding term sheet has been signed with Chinese State Owned Enterprise, Guizhou Geological and Mineral Resources Development Company Limited for the sale of Kyrgyz mineral assets for cash consideration of US$10.0 million. A separate agreement also signed for sale of Savoyardy assets (excluded from the GGMRD transaction) for cash consideration of US$0.

 
Manas Resources Ltd to update on Kyrgyz gold assets

2016-08-28 proactiveinvestors.com.au
Manas Resources Ltd (ASX:MSR) has been granted a trading halt by the ASX this morning, with its shares placed in pre-open. Manas requested the halt pending a transaction concerning the Kyrgyz gold assets. The halt will remain in place until the opening of trade on Wednesday 31st August 2016, or earlier if an announcement is made to the market.

 
Geophysical Study of Sultan Sary Gold Project

2016-08-25 londonstockexchange
Legendary is pleased to announce that following the positive exploration results from the work carried out by Manas Resources LLP ("MR LLP") (announced on 11 April 2016), MR LLP has initiated a geophysical work programme to better define and delineate known and potential gold mineralisation in the 66km2 license area in Sultan Sary, Narynskaya Oblast, Kyrgyzstan.

 
Manas Resources Ltd is Thursday's ASX Most Traded with 150 million

2016-08-11 proactiveinvestors.com.au
Proactive Investors is a global leader reporting financial news, media, research and hosts events for listed emerging growth companies and investors across four continents.

 
Manas Resources Ltd is Friday's ASX Volume Leader late in the session

2016-07-29 proactiveinvestors.com.au
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

 
Manas Resources Ltd is Thursday's ASX Most Traded with 82 million

2016-06-30 proactiveinvestors.com.au
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...